LAFSX
Price
$19.11
Change
-$0.14 (-0.73%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

LAFSX vs RMFCX

Header iconLAFSX vs RMFCX Comparison
Open Charts LAFSX vs RMFCXBanner chart's image
Lord Abbett Affiliated R4
Price$19.11
Change-$0.14 (-0.73%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
LAFSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAFSX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFSX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. LAFSX (6.32B). RMFCX pays higher dividends than LAFSX: RMFCX (1.69) vs LAFSX (1.49). LAFSX was incepted earlier than RMFCX: LAFSX (9 years) vs RMFCX (23 years). LAFSX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). LAFSX has a lower initial minimum investment than RMFCX: LAFSX (0) vs RMFCX (250). LAFSX annual gain was more profitable for investors over the last year : 16.15 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. LAFSX (27.45).
LAFSXRMFCXLAFSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD14.79911.423130%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B104B6%
Annual Yield % from dividends1.491.6988%
Returns for 1 year16.1512.63128%
Returns for 3 years9.8414.1669%
Returns for 5 years27.4540.3968%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc